277 related articles for article (PubMed ID: 23695449)
21. Galectins as potential emerging key targets in different types of leukemia.
Zheng Y; Feng W; Wang YJ; Sun Y; Shi G; Yu Q
Eur J Pharmacol; 2019 Feb; 844():73-78. PubMed ID: 30452910
[TBL] [Abstract][Full Text] [Related]
22. Redundant and antagonistic functions of galectin-1, -3, and -8 in the elicitation of T cell responses.
Tribulatti MV; Figini MG; Carabelli J; Cattaneo V; Campetella O
J Immunol; 2012 Apr; 188(7):2991-9. PubMed ID: 22357632
[TBL] [Abstract][Full Text] [Related]
23. The role of galectins in colorectal cancer progression.
Barrow H; Rhodes JM; Yu LG
Int J Cancer; 2011 Jul; 129(1):1-8. PubMed ID: 21520033
[TBL] [Abstract][Full Text] [Related]
24. Galectins as therapeutic targets for hematological malignancies: a hopeful sweetness.
Pena C; Mirandola L; Figueroa JA; Hosiriluck N; Suvorava N; Trotter K; Reidy A; Rakhshanda R; Payne D; Jenkins M; Grizzi F; Littlefield L; Chiriva-Internati M; Cobos E
Ann Transl Med; 2014 Sep; 2(9):87. PubMed ID: 25405162
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic potential of Galectin-9 in human disease.
Wiersma VR; de Bruyn M; Helfrich W; Bremer E
Med Res Rev; 2013 Jun; 33 Suppl 1():E102-26. PubMed ID: 21793015
[TBL] [Abstract][Full Text] [Related]
26. Galectins and urological cancer.
Oka N; Takenaka Y; Raz A
J Cell Biochem; 2004 Jan; 91(1):118-24. PubMed ID: 14689585
[TBL] [Abstract][Full Text] [Related]
27. Galectins: emerging regulatory checkpoints linking tumor immunity and angiogenesis.
Méndez-Huergo SP; Blidner AG; Rabinovich GA
Curr Opin Immunol; 2017 Apr; 45():8-15. PubMed ID: 28088061
[TBL] [Abstract][Full Text] [Related]
28. Intracellular galectins in cancer cells: potential new targets for therapy (Review).
Vladoiu MC; Labrie M; St-Pierre Y
Int J Oncol; 2014 Apr; 44(4):1001-14. PubMed ID: 24452506
[TBL] [Abstract][Full Text] [Related]
29. A novel function for galectin-7: promoting tumorigenesis by up-regulating MMP-9 gene expression.
Demers M; Magnaldo T; St-Pierre Y
Cancer Res; 2005 Jun; 65(12):5205-10. PubMed ID: 15958565
[TBL] [Abstract][Full Text] [Related]
30. Galectin-loaded cells as a platform for the profiling of lectin specificity by fluorescent neoglycoconjugates: a case study on galectins-1 and -3 and the impact of assay setting.
Rapoport EM; André S; Kurmyshkina OV; Pochechueva TV; Severov VV; Pazynina GV; Gabius HJ; Bovin NV
Glycobiology; 2008 Apr; 18(4):315-24. PubMed ID: 18256179
[TBL] [Abstract][Full Text] [Related]
31. Psoriasis in humans is associated with down-regulation of galectins in dendritic cells.
de la Fuente H; Perez-Gala S; Bonay P; Cruz-Adalia A; Cibrian D; Sanchez-Cuellar S; Dauden E; Fresno M; García-Diez A; Sanchez-Madrid F
J Pathol; 2012 Oct; 228(2):193-203. PubMed ID: 22271227
[TBL] [Abstract][Full Text] [Related]
32. [Galectin expression in urological cancer. Diagnostic, prognostic and therapeutic potential].
Waalkes S; Merseburger AS; Simon A; Serth J; Kuczyk MA
Urologe A; 2010 Mar; 49(3):387-91. PubMed ID: 20238481
[TBL] [Abstract][Full Text] [Related]
33. Immunotherapy of hematological malignancies using dendritic cells.
Van de Velde AL; Berneman ZN; Van Tendeloo VF
Bull Cancer; 2008 Mar; 95(3):320-6. PubMed ID: 18390412
[TBL] [Abstract][Full Text] [Related]
34. Galectin-9 in tumor biology: a jack of multiple trades.
Heusschen R; Griffioen AW; Thijssen VL
Biochim Biophys Acta; 2013 Aug; 1836(1):177-85. PubMed ID: 23648450
[TBL] [Abstract][Full Text] [Related]
35. [Vertebrate galectins: structure and function, role in tumoral process].
Bassen R; Brichory F; Caulet-Maugendre S; Delaval P; Dazord L
Bull Cancer; 2000 Oct; 87(10):703-7. PubMed ID: 11084533
[TBL] [Abstract][Full Text] [Related]
36. Angiogenesis, angiogenic factor expression and hematological malignancies.
Ribatti D; Vacca A; De Falco G; Roccaro A; Roncali L; Dammacco F
Anticancer Res; 2001; 21(6B):4333-9. PubMed ID: 11908688
[TBL] [Abstract][Full Text] [Related]
37. Medawar's PostEra: Galectins Emerged as Key Players During Fetal-Maternal Glycoimmune Adaptation.
Menkhorst E; Than NG; Jeschke U; Barrientos G; Szereday L; Dveksler G; Blois SM
Front Immunol; 2021; 12():784473. PubMed ID: 34975875
[TBL] [Abstract][Full Text] [Related]
38. The sweet and bitter sides of galectins in melanoma progression.
Braeuer RR; Shoshan E; Kamiya T; Bar-Eli M
Pigment Cell Melanoma Res; 2012 Sep; 25(5):592-601. PubMed ID: 22672152
[TBL] [Abstract][Full Text] [Related]
39. A modified version of galectin-9 induces cell cycle arrest and apoptosis of Burkitt and Hodgkin lymphoma cells.
Makishi S; Okudaira T; Ishikawa C; Sawada S; Watanabe T; Hirashima M; Sunakawa H; Mori N
Br J Haematol; 2008 Aug; 142(4):583-94. PubMed ID: 18503581
[TBL] [Abstract][Full Text] [Related]
40. Regulation of cellular homeostasis by galectins.
Hsu DK; Liu FT
Glycoconj J; 2002; 19(7-9):507-15. PubMed ID: 14758074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
